• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Product › Details

iPSC technology (induced pluripotent stem cell technology)

	Next higher product group	stem cell technology

Record changed: 2022-05-17

Advertisement

More documents for iPSC technology (induced pluripotent stem cell technology)

• [1] TreeFrog Therapeutics S.A.S.. (6/10/22). "Press Release: Umoja Biopharma and TreeFrog Therapeutics Announce Collaboration to Address Current Challenges Facing ex vivo Allogeneic Therapies in Immuno-oncology". Seattle, WA & Pessac....
• [2] Evotec SE. (5/17/22). "Press Release: Evotec and Sernova Announce Exclusive Strategic Partnership for iPSC-based Beta Cell Replacement Therapy to Advance a 'Functional Cure' for Diabetes". Hamburg & London, ON....
• [3] Quell Therapeutics Ltd.. (4/27/22). "Press Release: Quell Therapeutics and Cellistic Enter a Strategic Collaboration to Develop an iPSC-derived Allogeneic T-regulatory (Treg) Cell Therapy Platform". London & Gosselies....
• [4] Axol Bioscience Ltd.. (4/7/22). "Press Release: Axol Bioscience Raises £3.2 Million GBP (c. $4.2 Million USD)". Cambridge....
• [5] Ncardia Services B.V.. (2/24/22). "Press Release: Ncardia Appoints Andy Holt as Chief Commercial Officer". Leiden....
• [6] Evotec SE. (1/25/22). "Press Release: Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology". Hamburg....
• [7] DefiniGen Ltd.. (1/20/22). "Press Release: DefiniGen Appoints Dr Chris Kirton as Chief Executive Officer". Cambridge....
• [8] Ncardia. (11/16/21). "Press Release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings". Gosselies & New York, NY....
• [9] Clade Therapeutics. (11/3/21). "Press Release: Clade Therapeutics Raises $87 Million Series A Financing to Realize the Potential of Cell Therapy". Cambridge, MA....
• [10] Evotec SE. (10/8/21). "Press Release: Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include Novel Cell Type". Hamburg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.